文獻名: Calcium phosphate nanocapsule crowned multiwalled carbon nanotubes for pH triggered intracellular anticancer drug release
作者:Shashwat S. Banerjee,a Kiran J. Todkar,a Ganesh V. Khutale,a Govind P. Chate,b Ankush V. Biradar,c Manoj B. Gawande,d Radek Zboril,d and Jayant J. Khandareb
a Actorius Innovations and Research, 100 NCL Innovation Park, Pune-411008, India
b Maharashtra Institute of Pharmacy, Maharashtra Institute of Technology Campus, Kothrud, Pune-411038, India
c Catalysis Division, CSIR-National Chemical Laboratory, Pune-411008, India
d Regional Centre of Advanced Technologies and Materials, Faculty of Science, Department of Physical Chemistry, Palacky University, Šlechti? 11, Olomouc, Czech Republic
摘要:We report calcium phosphate (CaP) nanocapsule crowned multiwalled carbon nanotubes (CNT–GSH–G4–CaP) as a novel platform for intracellular delivery of an anticancer drug. As a proof-of-concept, CNT–GSH–G4–CaP demonstrates release of anticancer drug doxorubicin hydrochloride (DOX) within intracellular lysosomes from the interior cavity of CNT upon pH triggered CaP dissolution. Importantly, we found that the CNT with a CaP nanolid can efficiently prevent untimely drug release at physiological pH but promotes DOX release at increased acidic milieu as observed in subcellular compartments such as lysosomes (5.0). This “zero premature release” characteristic is of clinical significance in delivering cytotoxic drugs, by reducing systemic toxicity and thus beneficial for the effective anticancer treatment. We envision that this pH triggered CaP crowned CNT nanosystem would lead to a new generation of self-regulated platforms for intracellular delivery of a variety of anticancer drugs.
免責聲明
- 凡本網(wǎng)注明“來源:化工儀器網(wǎng)”的所有作品,均為浙江興旺寶明通網(wǎng)絡有限公司-化工儀器網(wǎng)合法擁有版權或有權使用的作品,未經(jīng)本網(wǎng)授權不得轉載、摘編或利用其它方式使用上述作品。已經(jīng)本網(wǎng)授權使用作品的,應在授權范圍內使用,并注明“來源:化工儀器網(wǎng)”。違反上述聲明者,本網(wǎng)將追究其相關法律責任。
- 本網(wǎng)轉載并注明自其他來源(非化工儀器網(wǎng))的作品,目的在于傳遞更多信息,并不代表本網(wǎng)贊同其觀點和對其真實性負責,不承擔此類作品侵權行為的直接責任及連帶責任。其他媒體、網(wǎng)站或個人從本網(wǎng)轉載時,必須保留本網(wǎng)注明的作品第一來源,并自負版權等法律責任。
- 如涉及作品內容、版權等問題,請在作品發(fā)表之日起一周內與本網(wǎng)聯(lián)系,否則視為放棄相關權利。